期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 偏慢,4-8周

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.

Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:

Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.

《抗癌治療專(zhuān)家評(píng)論》（ISSN 1473-7140）對(duì)癌癥治療的主要趨勢(shì)提供專(zhuān)家評(píng)估和評(píng)論，并強(qiáng)調(diào)新的治療和診斷方法的表現(xiàn)。

內(nèi)容包括腫瘤管理、新型藥物、抗癌劑和化療、生物治療、癌癥疫苗、治療指征、生物標(biāo)志物和診斷以及治療指南。所有文章都經(jīng)過(guò)嚴(yán)格的同行評(píng)審，該期刊對(duì)癌癥治療的決策做出了重要貢獻(xiàn)。

每篇評(píng)論的全面報(bào)道都由獨(dú)特的專(zhuān)家評(píng)論格式補(bǔ)充，并包括以下部分：

專(zhuān)家意見(jiàn) - 對(duì)文章中呈現(xiàn)的數(shù)據(jù)的個(gè)人看法，對(duì)未來(lái)可能重要的發(fā)展進(jìn)行討論，以及隨著進(jìn)一步研究產(chǎn)生更詳細(xì)的結(jié)果，可能變得令人興奮的研究途徑

文章重點(diǎn) - 作者最關(guān)鍵觀點(diǎn)的執(zhí)行摘要。

《Expert Review Of Anticancer Therapy》(抗癌治療專(zhuān)家評(píng)論)編輯部通訊方式為EXPERT REVIEWS, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢(xún)我們的客服老師。我們專(zhuān)注于期刊咨詢(xún)服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。